Company profile
Lexeo Therapeutics
Advancing science with curative potential for both cardiovascular and APOE4 associated Alzheimer's disease areas.
- Industry
- Biotechnology Research
- Employees
- 93
- Headquarters
- New York, New York
- Founded
- 2018
- LinkedIn followers
- 17,792
- Office locations
- 1
Lexeo Therapeutics company summary
Lexeo Therapeutics is a company in the Biotechnology Research industry, headquartered in New York, New York, founded in 2018. On LinkedIn the company has around 93 employees and 17,792 followers.
What technology does Lexeo Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Lexeo Therapeutics
Based in New York City, Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Building on groundbreaking research from Weill Cornell Medicine and the University of California San Diego, Lexeo partners with preeminent institutions on the cutting edge of gene therapy research. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4 associated Alzheimer's disease programs, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing and commercialization. For more information, please visit www.lexeotx.com.
Where is Lexeo Therapeutics located?
Lexeo Therapeutics lists 1 location.
Compare companies similar to Lexeo Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Lexeo Therapeutics lexeotx.com | Biotechnology Research | 93 | 2018 | New York, New York |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Lexeo Therapeutics
What does Lexeo Therapeutics do?
Based in New York City, Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Building on groundbreaking research from Weill Cornell Medicine and the University of California San Diego, Lexeo partners with preeminent institutions on the cutting edge of gene therapy research. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4 associated Alzheimer's disease programs, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing and commercialization. For more information, please visit www.lexeotx.com.
How many employees does Lexeo Therapeutics have?
Lexeo Therapeutics has around 93 employees on LinkedIn.
Where is Lexeo Therapeutics headquartered?
Lexeo Therapeutics is headquartered in New York, New York.
When was Lexeo Therapeutics founded?
Lexeo Therapeutics was founded in 2018.
Build a lead list from companies like Lexeo Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.